Grund Nicholas — SEC Form 4 filings

SEC reporting owner CIK 1661887. 4 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-02 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Akebia Therapeutics, Inc. (AKBA)Chief Commercial Officer43 legs · 140,450 sh · $234,7166

Form 4 filings — Grund Nicholas

FiledFormIssuerReported transactionsSource
2026-02-044Akebia Therapeutics, Inc. (AKBA)Sale (S): 53,585 @ $1.39 · Sale (S): 31,244 @ $1.39EDGAR
2026-02-034Akebia Therapeutics, Inc. (AKBA)Grant/award (A): 204,000 @ $0 · Grant/award (A): 320,000 (derivative) @ $0EDGAR
2025-02-044Akebia Therapeutics, Inc. (AKBA)Grant/award (A): 194,900 @ $0 · Sale (S): 55,621 @ $2.10 · Grant/award (A): 292,300 (derivative) @ $0EDGAR
2024-02-024Akebia Therapeutics, Inc. (AKBA)Grant/award (A): 303,300 @ $0 · Grant/award (A): 454,950 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1661887 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →